Researchers at Mayo Clinic have identified five distinct biological subtypes of fatty liver disease, each carrying different risks for severe health complications.
An experimental compound from Michigan Medicine reverses severe fatty liver disease in animal studies by repairing the gut barrier and reducing harmful bacteria.
